Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
NCT06866483 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2025-03-10
Summary
This study expands and validates the pilot study NCT06381284. It is a fully remote, site-less, prospective, observational study enrolling adults in the United States (excluding U.S. territories) with undiagnosed neuromuscular symptoms. The primary objective is to determine the validity of a self-assessment tool in encouraging undiagnosed participants, recruited through a social media campaign, to seek medical evaluation for suspected myasthenia gravis (MG).
Conditions
- Myasthenia Gravis
- Neuromuscular Disease
- Neuromuscular Manifestations
Interventions
- BEHAVIORAL
-
Social media recruitment
Social media users exposed to a variety of paid social media advertisements as a recruitment tool for study enrollment
- BEHAVIORAL
-
Self-Assessment
Eligible participants are asked to complete self-administered physical tests to assess inducible fatigue of specific muscle groups
- BEHAVIORAL
-
Follow-up
Patients triaged based on their assessed risk of MG are asked to complete recommended follow-up with a clinician to determine presence of myasthenia gravis
Sponsors & Collaborators
-
UCB Pharma
collaborator INDUSTRY -
University of California, San Francisco
collaborator OTHER -
ZS Associates
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-02-26
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- United States
Study Locations
More Related Trials
-
Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
NCT00727194 ·Status: TERMINATED ·Phase: PHASE2
-
A Prospective Cohort Study of Myasthenia Gravis in China
NCT06006832 ·Status: RECRUITING
-
Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis
NCT06106672 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis
NCT01555580 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Detecting Fatigue From Voice in Generalised Myasthenia Gravis
NCT07033559 ·Status: NOT_YET_RECRUITING
-
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
NCT06298552 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis
NCT01828294 ·Status: TERMINATED ·Phase: PHASE1
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis
NCT06064695 ·Status: RECRUITING ·Phase: NA
-
Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis
NCT02565576 ·Status: COMPLETED ·Phase: PHASE2
-
The Impact of Myasthenia Gravis in the Real World
NCT04176211 ·Status: COMPLETED
-
Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod
NCT07072988 ·Status: RECRUITING ·Phase: PHASE4
-
Biomarkers for Fatigue in Patients with Myasthenia Gravis
NCT06860347 ·Status: COMPLETED
-
Exploring Outcomes and Characteristics of Myasthenia Gravis 2
NCT06002945 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis
NCT05067348 ·Status: RECRUITING ·Phase: PHASE2
-
Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China
NCT04535843 ·Status: RECRUITING
-
A Prospective Cohort Study Of Myasthenia Gravis
NCT04674605 ·Status: UNKNOWN
-
Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients
NCT06742255 ·Status: NOT_YET_RECRUITING
-
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis
NCT06558279 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
NCT05564936 ·Status: RECRUITING ·Phase: NA
-
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
NCT07217587 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
NCT03971422 ·Status: COMPLETED ·Phase: PHASE3
-
Education Program in Myasthenia
NCT04714658 ·Status: UNKNOWN ·Phase: NA
-
Therapeutic Plasma Exchange in MG
NCT01927692 ·Status: COMPLETED
-
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
NCT04951622 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis
NCT06688435 ·Status: RECRUITING ·Phase: PHASE1